中国乙型肝炎病毒B基因型、C基因型与干扰素疗效的关系

李庭明; 朱幼芙; 何海棠; 毛乾国; 吴爱华; 梁蔚芳; 骆抗先

中国乙型肝炎病毒B基因型、C基因型与干扰素疗效的关系

基金项目:

军队九五研究基金 (NO.0 1Z0 4 6)；

详细信息

中图分类号: R512.62
计量
- 文章访问数: 2171
- HTML全文浏览量: 17
- PDF下载量: 741
- 被引次数: 0
出版历程
- 出版日期: 2005-01-20

The relation between chinese hepatitis B virus genotype B C and efficacy of interferon-α.

Research funding:

摘要

摘要: 探讨中国乙型肝炎病毒基因型与干扰素α疗效的关系。用PCR -限制性酶切片段长度多态性方法分析乙型肝炎病毒基因型 ,并研究 1998 1～ 2 0 0 2 4南方医院门诊和住院慢性乙型肝炎患者的一般人口学、ALT、HBVDNA、肝脏活检组织病理以及干扰素治疗效果。B基因型 70例 ,C基因型 6 0例 ,两基因型间一般人口学、ALT、HBVDNA、肝脏活检组织病理无统计学差异 ,干扰素治疗效果同样没有显著性差异。HBVB、C基因型感染的慢性乙型肝炎患者临床无统计学差异 ,可能与两组患者有着相似的免疫背景有关
- HBV /
- 基因型 /
- 干扰素-α /
- 慢性乙型肝炎
Abstract: To investigate the relation between chinese hpatitis B virus (HBV) genotype and efficacy of interferon-α.HBV genetype was testified by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) .Common demography, Alanine aminotransferase (ALT) , HBVDNA, liver biopsy, and efficacy of interferon-α of chronic hepatitis B (CHB) patients of Nanfang Hospital during 1998.1-2002.4 were surveyed.Patients with CHB caused by HBV B or C genotype have not any significante difference neither in common demography, ALT, HBV DNA, liver biopsy, nor in efficacy of interferon-α Patients infected with HBV B or C genotype have no significante difference in clinic, probably correlated to the similar immune background of two groups.
- HBV /
- genotype /
- interferon-α /
- chronic hepatitis B

HTML全文

参考文献(24)

[1] OkamotoH , TsudaF , SakugawaH , etal.TypinghepatitisBvirusbyhomologyinnucleotidesequencecomparisonofsurfaceantigensub types[J].JGenVirol, 1988, 69 (10) ∶2575-2583.

[2] NorderH , HammasB , LofdahlS , etal.ComparisonoftheaminoacidsequencesofninedifferentserotypesofhepatitisBsurfaceantigenandgenomicclassificationofthecorrespondinghepatitisBvirusstrains[J].JGenVirol, 1992, 73∶1201-1208.

[3] StuyverL , DeGendtS , VanGeytC , teal.AnewgenotypeofhepatitisBvirus∶completegenomeandphylogeneticrelatedness[J].JGenVi rol, 2000, 81∶67-74.

[4] Arauz-RuizP , NorderH , RobertsonBH , etal.GenotypeH :anewAmerindiangenotypeofhepatitisBvirusreveakedinCentrakAmerica[J].JGenVirol, 2002, 83 (Pt8) ∶2059-2073.

[5] NorderH , HammasB , LeeS -D , etal.GeneticrelatednessofhepatitisBviralstrainsofdiversegeographicaloriginandnaturalvariationsintheprimarystructureofthesurfaceantigen[J].JGenVirol, 1993, 74∶1341-1348.

[6] KaoJH , ChenPJ, LaiMY , etal.HepatitisBgenotypescorrelatewithclinicaloutcomesin patientswithchronichepatitisB[J].Gastroen terology, 2000, 118∶554-559.

[7]许军, 王齐欣, 蒋栋, 等.乙型肝炎病毒基因型与病情轻重的关系.[J].中华肝脏病杂志, 2003, 11∶11-13.

[8]夏国良, OmanaVNainan, 贾志远, 等.乙型肝炎病毒基因型和血清亚型在我国部分地区的分布及其特点[J].中华流行病学杂志, 2001, 22∶348-351.

[9] SugauchiF , OritoE , IchidaT , etal.HepatitisBvirusofgenotypeBwithorwithoutrecombinationwithgenotypeCovertheprecorere gionplusthecoregene[J].JVirol, 2002, 76 (12) ∶5985-5992.

[10] ChanHL , WongML , HuiAY , etal.HepatitisBvirusgenotypeCtakesamoreaggressivediseasecoursethanhepatitisBvirusgenotypeBinhepatitisBeantigen-positivepatients[J].JCnMicrobiol, 2003, 41∶1277-1279.

[11] LeeCM , ChenCH , LuSN , etal.PrevalenceandclinicalimplicationsofhepatitisBvirusgenotypesinsouthernTaiwan[J].ScandJGas troenterol, 2003, 38∶95-101.

[12] YuenMF , SablonE , YuanHJ, etal.SignificanceofhepatitisBgeno typeinacuteexacerbation, HBeAgseroconversion, cirrhosis-relatedcomplications, andhepatocellularcarcinoma[J].Hepatology, 2003, 37∶562-567.

[13] ChanHL , TsangSW , WongML , etal.GenotypeBhepatitisBvirusisassociatedwithsevereictericflare-upofchronichepatitisBvirusinfectioninHongKong[J].AmJGastroenterol, 2002, 97∶2629-2633.

[14] ChanHL , TsangSW , LiewCT , etal.ViralgenotypeandhepatitisBviruxDNAlevelsarecorrelatedwithhistologicalliverdamageinHBeAg-negativechronichepatitisBvirusinfection[J].AmJGas troenterol, 2002, 97∶406-412.

[15] ChuCJ, HussainM , LokAS .HepatitisBvirusgenotypeBisassociat edwithearlierHBeAgseroconversioncomparedwithhepatitisBvirusgenotypeC[J].Gastroenterology, 2002, 122∶1756-1762.

[16] DingX , MizokamiM , GeX , etal.DifferenthepatitisBvirusgeno typedistributionsamongasymptomaticcarriersandpatientswithliverdiseasesinNanning, southernChina[J].HepatolRes, 2002, 22∶37-44.

[17] DingX , MizokamiM , YaoG , etal.HepatitisBvirusgenotypedistri butionamongchronichepatitisBviruscarriersinShanghai, China[J].Intervirology, 2001, 44∶43-47.

[18] KaoJH , ChenPJ , LaiMY , etal.GenotypesandclinicalphenotypesofhepatitisBvirusin patientswithchronichepatitisBvirusinfection[J].ClinMicrobiol, 2002, 40∶1207-1209.

[19] KaoJH , ChenPJ , LaiMY , etal.ClinicalandvirologicalaspectsofblooddonorsInfectedwithhepatitisBvirusgenotypesBandC[J].JClinMicrobiol, 2002, 40∶22-25.

[20] ChuCJ, LokAS .ClinicalsignificanceofhepatitisBvirusgenotypes[J].Hepatology, 2002, 35∶1274-1276.

[21] 中华医学会.病毒性肝炎防治方案[J].中华肝脏病杂志, 2000, 6∶324-329.

[22]阎丽, 侯金林, 郭亚兵, 等.乙型肝炎病毒基因型S基因PCR -RFLP分型方法的建立[J].中华传染病杂志, 2001, 19∶224-228.

[23]骆抗先.乙型肝炎基础和临床[M].第2版.北京:人民卫生出版社, 2001∶381-395.

[24]姚光弼.慢性病毒性肝炎治疗的策略及实施[J].现代实用医学, 2003, 15∶2-4.

施引文献

资源附件(0)

访问统计